Your browser doesn't support javascript.
loading
Effect of adjuvant trastuzumab among patients treated with anti-HER2-based neoadjuvant therapy.
Gonzalez-Angulo, A M; Parinyanitikul, N; Lei, X; Mittendorf, E A; Zhang, H; Valero, V; Hunt, K K; Hortobagyi, G N; Chavez-MacGregor, M.
Affiliation
  • Gonzalez-Angulo AM; 1] Department of Breast Medical Oncology at The University of Texas, MD Anderson Cancer Center, Houston, TX, USA [2] Department of Systems Biology at The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
  • Parinyanitikul N; Department of Breast Medical Oncology at The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
  • Lei X; Department of Biostatistics at The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
  • Mittendorf EA; Department of Surgical Oncology at The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
  • Zhang H; Department of Pathology at The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
  • Valero V; Department of Breast Medical Oncology at The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
  • Hunt KK; Department of Surgical Oncology at The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
  • Hortobagyi GN; Department of Breast Medical Oncology at The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
  • Chavez-MacGregor M; 1] Department of Breast Medical Oncology at The University of Texas, MD Anderson Cancer Center, Houston, TX, USA [2] Department of Health Services Research at The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
Br J Cancer ; 112(4): 630-5, 2015 Feb 17.
Article in En | MEDLINE | ID: mdl-25584488
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Carcinoma, Ductal, Breast / Receptor, ErbB-2 / Protein Kinase Inhibitors / Antibodies, Monoclonal, Humanized Type of study: Observational_studies / Risk_factors_studies Language: En Journal: Br J Cancer Year: 2015 Type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Carcinoma, Ductal, Breast / Receptor, ErbB-2 / Protein Kinase Inhibitors / Antibodies, Monoclonal, Humanized Type of study: Observational_studies / Risk_factors_studies Language: En Journal: Br J Cancer Year: 2015 Type: Article Affiliation country: United States